dapsone

  1. Zydus gets final approval from USFDA to market generic arthritis drug

    Zydus gets final approval from USFDA to market generic arthritis drug

    The company received approval to market Dexamethasone Tablets USP, 1 mg in the US.Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders...
  2. Zydus gets final approval from USFDA for acne treatment Dapsone Gel

    Zydus gets final approval from USFDA for acne treatment Dapsone Gel

    Dapsone gel is used to treat acne and will be manufactured at the group's topical manufacturing facility in Changodar, Ahmedabad, Gujarat.Citing March 2024 IQVIA MAT (moving annual total) data, the company said annual US sales of 7.5 percent Dapson Gel were $35.8 million.The company said...
  3. Zydus Lifesciences gets USFDA nod for acne treatment gel

    Zydus Lifesciences gets USFDA nod for acne treatment gel

    New Delhi, Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to market the generic version of Dapsone Gel, used to treat acne.The final approval by the US Food and Drug Administration (USFDA) is for Dapsone Gel in 7.5 per cent strength, Zydus...
Back
Top